4GKI | pdb_00004gki

Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NM-PP1


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.88 Å
  • R-Value Free: 
    0.216 (Depositor), 0.218 (DCC) 
  • R-Value Work: 
    0.166 (Depositor), 0.168 (DCC) 
  • R-Value Observed: 
    0.168 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 4GKI

Ligand Structure Quality Assessment 


This is version 1.6 of the entry. See complete history

Literature

Structure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistance.

Stogios, P.J.Spanogiannopoulos, P.Evdokimova, E.Egorova, O.Shakya, T.Todorovic, N.Capretta, A.Wright, G.D.Savchenko, A.

(2013) Biochem J 454: 191-200

  • DOI: https://doi.org/10.1042/BJ20130317
  • Primary Citation Related Structures: 
    4EJ7, 4FEU, 4FEV, 4FEW, 4FEX, 4GKH, 4GKI

  • PubMed Abstract: 

    Activity of the aminoglycoside phosphotransferase APH(3')-Ia leads to resistance to aminoglycoside antibiotics in pathogenic Gram-negative bacteria, and contributes to the clinical obsolescence of this class of antibiotics. One strategy to rescue compromised antibiotics such as aminoglycosides is targeting the enzymes that confer resistance with small molecules. We demonstrated previously that ePK (eukaryotic protein kinase) inhibitors could inhibit APH enzymes, owing to the structural similarity between these two enzyme families. However, limited structural information of enzyme-inhibitor complexes hindered interpretation of the results. In addition, cross-reactivity of compounds between APHs and ePKs represents an obstacle to their use as aminoglycoside adjuvants to rescue aminoglycoside antibiotic activity. In the present study, we structurally and functionally characterize inhibition of APH(3')-Ia by three diverse chemical scaffolds, anthrapyrazolone, 4-anilinoquinazoline and PP (pyrazolopyrimidine), and reveal distinctions in the binding mode of anthrapyrazolone and PP compounds to APH(3')-Ia compared with ePKs. Using this observation, we identify PP derivatives that select against ePKs, attenuate APH(3')-Ia activity and rescue aminoglycoside antibiotic activity against a resistant Escherichia coli strain. The structures described in the present paper and the inhibition studies provide an important opportunity for structure-based design of compounds to target aminoglycoside phosphotransferases for inhibition, potentially overcoming this form of antibiotic resistance.


  • Organizational Affiliation
    • Department of Chemical Engineering and Applied Chemistry, University of Toronto, Ontario, Canada.

Macromolecule Content 

  • Total Structure Weight: 388.64 kDa 
  • Atom Count: 30,104 
  • Modeled Residue Count: 3,171 
  • Deposited Residue Count: 3,264 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Aminoglycoside 3'-phosphotransferase AphA1-IAB
A, B, C, D, E
A, B, C, D, E, F, G, H, I, J, K, L
272Acinetobacter baumannii AYEMutation(s): 0 
Gene Names: ABAYE3578APHA1-IAB
EC: 2.7.1.95

Small Molecules

Ligands 6 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
KAN

Query on KAN



Download:Ideal Coordinates CCD File
BC [auth L]
EB [auth H]
HA [auth D]
KB [auth I]
M [auth A]
BC [auth L],
EB [auth H],
HA [auth D],
KB [auth I],
M [auth A],
MA [auth E],
OB [auth J],
UA [auth F],
V [auth B],
XB [auth K],
YA [auth G],
Z [auth C]
KANAMYCIN A
C18 H36 N4 O11
SBUJHOSQTJFQJX-NOAMYHISSA-N
0JN

Query on 0JN



Download:Ideal Coordinates CCD File
AA [auth C]
CC [auth L]
FB [auth H]
IA [auth D]
LB [auth I]
AA [auth C],
CC [auth L],
FB [auth H],
IA [auth D],
LB [auth I],
N [auth A],
NA [auth E],
PB [auth J],
VA [auth F],
W [auth B],
YB [auth K],
ZA [auth G]
1-tert-butyl-3-(naphthalen-1-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C20 H21 N5
GDQXJQSQYMMKRA-UHFFFAOYSA-N
PEG

Query on PEG



Download:Ideal Coordinates CCD File
NB [auth I]
U [auth A]
UB [auth J]
VB [auth J]
WB [auth J]
NB [auth I],
U [auth A],
UB [auth J],
VB [auth J],
WB [auth J],
Y [auth B]
DI(HYDROXYETHYL)ETHER
C4 H10 O3
MTHSVFCYNBDYFN-UHFFFAOYSA-N
ACT

Query on ACT



Download:Ideal Coordinates CCD File
AC [auth K]
CB [auth G]
DA [auth C]
DB [auth G]
EA [auth C]
AC [auth K],
CB [auth G],
DA [auth C],
DB [auth G],
EA [auth C],
EC [auth L],
FA [auth C],
FC [auth L],
GA [auth C],
GC [auth L],
HB [auth H],
IB [auth H],
JB [auth H],
KA [auth D],
LA [auth D],
MB [auth I],
PA [auth E],
QA [auth E],
R [auth A],
RA [auth E],
S [auth A],
SA [auth E],
SB [auth J],
T [auth A],
TA [auth E],
TB [auth J],
X [auth B],
XA [auth F]
ACETATE ION
C2 H3 O2
QTBSBXVTEAMEQO-UHFFFAOYSA-M
CL

Query on CL



Download:Ideal Coordinates CCD File
Q [auth A]CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M
NA

Query on NA



Download:Ideal Coordinates CCD File
AB [auth G]
BA [auth C]
BB [auth G]
CA [auth C]
DC [auth L]
AB [auth G],
BA [auth C],
BB [auth G],
CA [auth C],
DC [auth L],
GB [auth H],
JA [auth D],
O [auth A],
OA [auth E],
P [auth A],
QB [auth J],
RB [auth J],
WA [auth F],
ZB [auth K]
SODIUM ION
Na
FKNQFGJONOIPTF-UHFFFAOYSA-N
Modified Residues  1 Unique
IDChains TypeFormula2D DiagramParent
MSE
Query on MSE
A, B, C, D, E
A, B, C, D, E, F, G, H, I, J, K, L
L-PEPTIDE LINKINGC5 H11 N O2 SeMET

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.88 Å
  • R-Value Free:  0.216 (Depositor), 0.218 (DCC) 
  • R-Value Work:  0.166 (Depositor), 0.168 (DCC) 
  • R-Value Observed: 0.168 (Depositor) 
Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 96.843α = 103.24
b = 97.103β = 106.18
c = 112.128γ = 112.66
Software Package:
Software NamePurpose
HKL-3000data collection
PHENIXmodel building
PHENIXrefinement
XDSdata reduction
SCALAdata scaling
PHENIXphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Revision History  (Full details and data files)

  • Version 1.0: 2012-09-05
    Type: Initial release
  • Version 1.1: 2013-06-26
    Changes: Database references
  • Version 1.2: 2013-08-07
    Changes: Database references
  • Version 1.3: 2013-09-04
    Changes: Database references
  • Version 1.4: 2023-09-13
    Changes: Data collection, Database references, Derived calculations, Refinement description
  • Version 1.5: 2023-12-06
    Changes: Data collection
  • Version 1.6: 2024-11-20
    Changes: Structure summary